NAD+ Metabolism and NAD+-Dependent Enzymes: Promising Therapeutic Targets for Neurological Diseases

E-ISSN： 1873-5592|13|2|222-229

ISSN： 1389-4501

Source： Current Drug Targets, Vol.13, Iss.2, 2012-02, pp. : 222-229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NAD+/NADH Metabolism and NAD+-Dependent Enzymes in Cell Death and Ischemic Brain Injury: Current Advances and Therapeutic Implications

Current Medicinal Chemistry, Vol. 22, Iss. 10, 2015-01 ,pp. : 1239-1247

Bentham Science Publishers

Access to resources Recommend Favorite

The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases

By Cai H. Griendling K.K. Harrison D.G.

Trends in Pharmacological Sciences, Vol. 24, Iss. 9, 2003-09 ,pp. : 471-478

Elsevier

Access to resources Recommend Favorite

NAD Metabolism and Functions: A Common Therapeutic Target for Neoplastic, Metabolic and Neurodegenerative Diseases

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 23, 2013-12 ,pp. : 2918-2929

Bentham Science Publishers

Access to resources Recommend Favorite

Rehab of NAD(P)-Dependent Enzymes with NAD(P)-Based Inhibitors

Current Medicinal Chemistry, Vol. 18, Iss. 13, 2011-05 ,pp. : 1891-1908

Bentham Science Publishers

Access to resources Recommend Favorite

Cofactor Mimics as Selective Inhibitors of NAD-dependent Inosine Monophospate Dehydrogenase (IMPDH) - the Major Therapeutic Target

Current Medicinal Chemistry, Vol. 11, Iss. 7, 2004-04 ,pp. : 887-900

Bentham Science Publishers

Access to resources Recommend Favorite